Abstract
In the past few years important advances have been made in our understanding of the biology and natural history of CLL; also, new strategies and agents offer promise in the treatment of this form of leukemia. Now, patients can be treated on a more rationale basis and with real prospects for a sustained control of their disease, and improved quality of life. Hopefully, progresses in CLL will continue to accumulate in the coming years.
Publication types
-
Congress
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bone Marrow Transplantation
-
Gene Rearrangement, B-Lymphocyte
-
Growth Substances / metabolism
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
-
Leukemia, Lymphocytic, Chronic, B-Cell* / metabolism
-
Leukemia, Lymphocytic, Chronic, B-Cell* / pathology
-
Leukemia, Lymphocytic, Chronic, B-Cell* / therapy
-
Mice
-
Prognosis